Try it
General Medicine · Oncology: tumour lysis syndrome
Sample itemA 12-year-old boy with Burkitt lymphoma has urine output falling 24 hours after starting chemotherapy. Potassium is 6.4 mmol/L, phosphate 8.2 mg/dL, calcium 6.9 mg/dL, uric acid 14 mg/dL and creatinine is rising. Which measure is most appropriate for preventing and treating this complication?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Aggressive intravenous hydration with rasburicase
Rapid lysis of a bulky, highly proliferative tumour releases potassium, phosphate and nucleic acids, causing hyperkalaemia, hyperphosphataemia, secondary hypocalcaemia and hyperuricaemia, with acute kidney injury from urate and calcium phosphate crystals. High-risk patients receive vigorous hydration and rasburicase, which converts uric acid to soluble allantoin. Dialysis is needed for refractory cases.
Option by option
A. Allopurinol alone with fluid restriction
Allopurinol only blocks new urate formation and fluid restriction would worsen kidney injury.
B. Aggressive intravenous hydration with rasburicase (correct)
Correct. Hydration maintains urine flow and rasburicase rapidly removes existing uric acid.
C. Intravenous calcium to correct the hypocalcaemia
Calcium raises calcium-phosphate product and is given only for symptomatic hypocalcaemia.
D. Urinary alkalinisation with sodium bicarbonate
Alkalinisation promotes calcium phosphate precipitation and is no longer recommended.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- Oncology: tumour lysis syndromeAfter chemotherapy for high-grade lymphoma, a patient develops hyperkalaemia, hyperphosp…
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…